Total synthesis of remdesivir.
Tetrahedron Lett
; 88: 153590, 2022 Jan 05.
Article
en En
| MEDLINE
| ID: mdl-34908617
ABSTRACT
Remdesivir, the first drug approved by the FDA to treat COVID-19, is in high demand for patients infected with the SARS-CoV-2 virus. Herein, we report a facile approach minimizing the protecting group manipulations to afford remdesivir in good overall yield.
Texto completo:
1
Bases de datos:
MEDLINE
Idioma:
En
Revista:
Tetrahedron Lett
Año:
2022
Tipo del documento:
Article
País de afiliación:
India